Overview

This trial is active, not recruiting.

Conditions prediabetes, hypertension, obesity, cardiovascular disease
Sponsor Health Diagnostic Laboratory, Inc.
Start date August 2013
End date August 2018
Trial size 1000 participants
Trial identifier NCT01998867, R2013-1003

Summary

1. To develop a database containing matched information from dynamic tests of postprandial glycemic control (OGTT or MMTT), results of a broad panel of fasting biomarkers, and clinical information related to diabetes risk obtain through subject interview.

2. To use the database to identify fasting biomarkers and associated algorithms to best predict parameters derived from dynamic tests (OGTT or MMTT) such as Insulin Glucose Tolerance (IGT), impaired first phase insulin response, etc., controlling for clinical information such as current medication use.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective

Primary Outcomes

Measure
Identify fasting biomarkers and associated algorithms to predict parameters
time frame: Baseline

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Weight >95 Exclusion Criteria: - Prior diagnosis of Diabetes

Additional Information

Official title Identification of Fasting Biomarkers That Predict Responses to the Oral Glucose Tolerance Test (OGTT) and Mixed Meal Tolerance Test (MMTT)
Principal investigator Szilard Voros, MD
Trial information was received from ClinicalTrials.gov and was last updated in February 2015.
Information provided to ClinicalTrials.gov by Health Diagnostic Laboratory, Inc..